Mecamylamine Hydrochloride (Nexgen Pharma, Inc.)


Welcome to the PulseAid listing for the Mecamylamine Hydrochloride drug offered from Nexgen Pharma, Inc.. This Autonomic Ganglionic Blocker [EPC],Decreased Autonomic Ganglionic Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Nexgen Pharma, Inc.
NON-PROPRIETARY NAME: Mecamylamine Hydrochloride
SUBSTANCE NAME: MECAMYLAMINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Autonomic Ganglionic Blocker [EPC],Decreased Autonomic Ganglionic Activity [PE]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-03-19
END MARKETING DATE: 0000-00-00


Mecamylamine Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMecamylamine Hydrochloride from Nexgen Pharma, Inc.
LABELER NAME: Nexgen Pharma, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2.5(mg/1)
START MARKETING DATE: 2013-03-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0722-7183_b87994ee-26a5-4d00-99e7-796bc17961f1
PRODUCT NDC: 0722-7183
APPLICATION NUMBER: ANDA204054

Other MECAMYLAMINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Manchester PharmaceuticalsVecamyl
Nexgen Pharma, Inc.Mecamylamine Hydrochloride
Turing PharmaceuticalsVecamyl